CURRENT POSITIONS

Associate Professor of Medicine: July 2004 - present

Division of General Internal Medicine

University of California, San Diego School of Medicine

 

Associate Professor of Family and Preventive Medicine: July 2004-present

University of California, San Diego School of Medicine

 

Research Associate Professor: October 1998 – present

Department of Psychology

Social Science Research Institute

University of Southern California

 

Attending Physician: August 1996 – present

Division of General Internal Medicine

VA San Diego Healthcare System

 

Health Consultant, RAND: August 1996 - present

Santa Monica, CA

 

Robert Wood Johnson Generalist Physician Faculty Scholar: July 2003 – 2007

 

EDUCATION AND TRAINING

Robert Wood Johnson Clinical Scholar, UCLA: 1994 - 1996

Chief Medical Resident, West Los Angeles VA Medical Center: 1993 - 1994

Medical Resident, West Los Angeles VA Medical Center: 1990 - 1993

Postdoctoral Fellow, Computational Neurobiology Laboratory, Salk Institute: 1989 - 1990

MD, University of California, San Diego: June 1989

PhD, Biology, University of California, San Diego: June 1988

Medical Scientist Training Program, University of California, San Diego: June 1979

BS, Physics, Summa Cum Laude (4.0 GPA at age 19), University of Southern California: 1979

Physics graduate fellowship offers (declined), Harvard University and California Institute of Technology: 1979

 

PAST APPOINTMENTS

Assistant Professor, Dept. of Family and Preventive Medicine, UC San Diego: July 2002 – 2004

Assistant Professor, Dept. of Psychology, UC San Diego: July 2001 - 2004

Assistant Professor of Medicine, UC San Diego: April 1998 - July 2004

Research Assistant Professor, Dept. of Psychology, USC: June 1995 – 1998

Teaching Assistant, Cell Biology, UCSD Department of Biology: 1987; Physiology of Sensation and Perception, UCSD Department of Psychology: 1987; Endocrinology, UCSD Department of Biology: 1986; Neurobiology, UCSD Department of Biology: 1985; Genetics, UCSD Department of Biology: 1983, 1984

Jet Propulsion Laboratory, Engineer I: 1979

Jet Propulsion Laboratory, Technical Aide A: 1978

 

LICENSURE California, Issued October 8, 1991

 

BOARD CERTIFICATION American Board of Internal Medicine, September 1993

 

AWARDS, HONORS, FELLOWSHIPS

Royal Society of Medicine, Overseas Fellow, May 2010

Robert Wood Johnson Generalist Physician Faculty Scholar Award: 2003-2007

Who’s Who in America: 2000 - present

Fellow, AHA Council on Epidemiology and Prevention: 2000 - present

Fellow of the American Heart Association: July 2001

Associate Fellow, American Heart Association Council on Epidemiology and Prevention: elected March 25, 1999

Fellow, 23rd Annual American Heart Association 10-day Seminar on the Epidemiology and Prevention of Cardiovascular Diseases: 1997

Solomon Scholar Research Award, UCLA: 1992, 1993

Emma Josephine Bradley Bovard Award (for graduating USC senior with best academic record): 1979 (4.0 GPA Physics, age 19)

Phi Kappa Phi: 1979

Junior Phi Beta Kappa: 1978

 

PROFESSIONAL ACTIVITIES AND AFFILIATIONS

Department of Veterans Affairs Research Advisory Committee on Gulf War Veterans Illnesses: Scientific Director Jan 2002 - Sep 2003; Chief Scientist: Sep 2003 – 2005; Member 2005-present

Member, Cochrane Adverse Effects Methods Group, 2008-present

Advisory Board, The Science Network (http://www.tsntv.org/about/advisors.php): 2004 – present

Committee on Appointments and Promotions (DOMCAP), UCSD 2007-present

Biomedical Library Committee 2009-present

Senior Vice President, ISCHEM Corp: 2002 – present

Co-Organizer, Robert Wood Johnson Generalist Physician Faculty Scholar Program, premeeting 11-28-07, Coronado, CA

Planning Committee, Robert Wood Johnson Generalist Physician Faculty Scholar Program Annual Meeting (San Diego) 11-27 to 11-30 2007, Coronado, CA

Organizer, Robert Wood Johnson Generalist Physician Faculty Scholar Program (premeeting + meeting 11-29-06). Ft Lauderdale, CA

Planning Committee, Robert Wood Johnson Generalist Physician Faculty Scholar Program 2006 annual meeting (premeeting + meeting 11-28-06 to 12-1-06, Ft. Lauderdale)

Invited Nominator, Edge of Computation Science Prize (2005) http://www.edge.org/3rd_culture/prize05/prize05_index.html

Member, American Society for Preventive Cardiology: 2002 - present

Member, Stein Institute for Research on Aging: Aug 2001 – present

Pharmacy and Therapeutics Committee, VA San Diego Medical Center: 2001 – 2005

Member, American Heart Association, Council on Epidemiology and Prevention: 2000 – present

Member, American College of Physicians: March 1995 – ?

Family and Preventive Medicine (FPM) 221: Preventive Cardiopulmonary Risk Factor Assessment (annually 1999-2005) Participated annually as faculty, director of blood pressure testing component; and have lectured on cardiopulmonary risk factors

Attending physician, Emergency Room, West Los Angeles VA Medical Center: 1994 - 1997

Pharmacy and Therapeutics Committee, WLA VA Medical Center, 1993-1994

Ethics Committee, West LA VA Medical Center, 1991-1994

Judge, Performance Improvement Fair, VASDMC: May 2001 – May 2006; 2008

Peer Review, journals including: Annals of Internal Med, New Engl J Med, JAMA, Lancet, BMJ, Circulation, JACC, Am J Med, J Gen Internal Med, Medical Care, Tohoku J Exp Med, J Women’s Health, J Clin Epi, Am J Epi, Ann Epi, Contemp Clin Trials, Ann Behav Med, Psychosomatic Med, Psychiatric Services, Psychiatry Research, Biological Psychiatry, J Affective Disorders, Ann Surg, Neuropsychopharmacology, Muscle and Nerve, Am J Primatology, Complex Systems, Evolutionary Anthropology, Eur J Pharmacol, PLOS-ONE, BMJ Cases, Neuroscience Letters, others.

Peer Review quality: Received letters from Annals of Internal Medicine in 2007, 2008, 2009 stating they rate the quality of their reviews and that I was in the top 10% of reviewers by quality for the prior year.

Peer Review participation, Books: Oxford University Press

 

OTHER

Accompanied high-level mission to the Middle East, with Dr. Bernard Rostker (Assistant Secretary of Defense for Personnel and Manpower; then Undersecretary of the Navy), and several other DoD and Congress officials. Purpose: to brief officials from other nations regarding illness in Gulf War veterans and exposures in Persian Gulf War; and to perform fact collection; itinerary included Kuwait, Saudi Arabia, Egypt, and Israel: Oct 1997 – Nov 1997

 

RESEARCH GRANTS

Funded: Department of Defense Congressionally Directed Medical Research Program / Gulf War Veterans’ Illness Research Program Grant

Project Title: Oxidative Stress

Project Number: GW093063

Amount: $927,000 (includes indirect costs)

Dates: 9/01/2010 - 8/31/2013

           Principal Investigator: Beatrice A. Golomb

 

Funded: Department of Defense Congressionally Directed Medical Research Program/ Gulf War Veterans’ Illnesses Research Program Grant

Project Title: Exhaled Gas Frequency Comb Spectroscopy: Distinguishing Biomarkers in Gulf War Illness Syndrome

Project Number: GW093021

Amount: $742,296 (includes indirect costs)

Dates: 9/01/2010 - 8/31/2013

           Principal Investigator: John Repine, University of Colorado, Denver

           UCSD Site PI/ Co-Investigator: Beatrice Golomb

 

Funded: Department of Defense Congressionally Directed Medical Research Program / Gulf War Veterans’ Illnesses Research Program Grant

Project Title: Q10 for Gulf War Veterans

Project Number: GW060036

Amount: $718,261.53 (includes indirect costs)

Dates: 9/30/2007 - 9/29/2010

Principal Investigator: Beatrice A. Golomb

 

Funded: Autism Speaks

Project Title: Mitochondrial Etiology of Autism

Amount: $76,000

Dates: 1-09 – 12-09

Consortium award (3 PIs; above amount refers to portion allocated to Dr. Golomb)

Consortium PIs: Douglas Wallace; Richard Haas; Beatrice Golomb

 

Funded: NIH R34

Project Title: Coenzyme Q10 in Aging: A Planning Grant

Project Number: 1 R34 AG026338

Amount: $88,000

Dates: Aug 2005 - July 2007

Principal Investigator: Beatrice A. Golomb

 

Funded: RWJ Generalist Physician Faculty Scholar Award

Project title: Enhancing Postmarketing Drug Adverse Event Surveillance Through the

Internet: Statin Cholesterol Lowering Drugs

           Amount: $300,000 (total direct costs over 4 years)

           Dates: July 2003 – 2007

           Awardee: Beatrice A. Golomb

 

Funded: NIH RO1

           Project Title: Statins and Noncardiovascular Endpoints

Project Number: 98-1060

           Amount $4.19 million (Total direct costs over 5 years)

           Dates: Aug 1999 - July 2006

           Principal Investigator: Beatrice A. Golomb

Administrative Supplement to the above

           Amount (Total direct costs): $300,000

           Dates: Aug 2001 – Aug 2003

 

Funded: Academic Senate Interdisciplinary Course Development Award

           Project Title: Course: Evaluation of Evidence and Inference

           Amount: $9,000 (covers 50% graduate student x 2 quarters)

           Dates: July 2001 - Jan 2002

 

Funded: Harry Frank Guggenheim Foundation

           Project Title: Low Serum Cholesterol and Violent Behavior

           Amount: $30,000 per annum

           Dates: Jan 1996 – Jan 1998

           Principal Investigator: Beatrice A. Golomb

 

EXPERT PANEL PARTICIPATION

Panelist, NIH Contract Review, Use of Biological Samples from WHI, May 2008

Department of Veterans Affairs, Research Advisory Committee on Gulf War Illnesses: Jan 2002 – present.

Panelist, NIH (NHLBI) Program Project Review. February 2007.

Grant Review, International Coenzyme Q10 Association, 2007

Panelist, NIH (NHLBI) Review Panel on "Prevention of Cardiovascular Disease in Diabetes Mellitus: Clinical Center Network Proposals": June 1999.

Expert "panelist" for the Department of Defense in the Army After Next AMEDD Technical Workshop to advise strategies for troop health protection in the year 2025. MacLean, Virginia: June 13 1999 – June 18 1999.

Expert panelist for the Center for Health Policy Research/Health Care Financing Association “Normative Standards Project”, pertaining to normative standards for home health care (requested; participation aborted due to date conflict with Department of Defense panel above): June 1999.

Panelist and speaker, Violence Prevention Coalition of Greater Los Angeles meeting entitled "How might interdisciplinary models of research guide us to a better understanding of violence?" Los Angeles, CA: Nov 1998.

 

BRIEFINGS TO GOVERNMENT AGENCIES

“Coenzyme Q10 for Treatment in Gulf War Veterans.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: tbn

“Gulf War Illnesses, Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: Sept 16, 2008.

“Gulf War Illnesses, Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: April 08, 2008.

“Gulf War Illnesses, Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: July 15, 2007.

“Oxidative stress, mitochondria, and illness in Gulf War veterans: A hypothesis.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: April 24, 2007.

“Statin Side Effects.” Invited discussion with Senate Finance Committee representatives. Dickson Building, Capitol Hill, Washington DC: June 9, 2006.

“Gulf War Illnesses, Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: May 16, 2006.

“Gulf War Illnesses, Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: April 8, 2005.

“Gulf War Illnesses, Anthrax Vaccine.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: April 7, 2005.

 “Gulf War Illnesses, Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses. Washington DC: June 29, 2004.

“Gulf War Illnesses, Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: Feb 23, 2004.

“Gulf War Illnesses, Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: June 2003.

“Birth Defects in Gulf War Veterans, Gulf War Veterans Research Update.” Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: June 2003.

“Candidate Research Recommendations”, “Vaccines and illness in Gulf War Veterans”, Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: Feb 2003.

“Gulf War Veterans Illnesses, Research Update focusing on Acetylcholinesterase inhibitors.” Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: Feb 2003.

“Treatments for Gulf War Veterans: What has been tried, and what are candidate treatments?” “Vaccines and illness in Gulf War Veterans.” Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: Oct 2002.

“Vaccines and illness in Gulf War Veterans.” Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: Oct 2002.

"Acetylcholinesterase inhibitors and illness in Gulf War veterans." Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: June 26, 2002.

"Treatments for ill Gulf War veterans." Research Advisory Committee on Gulf War Veterans Illnesses (Committee meeting open to the public). Washington DC: Feb 2002.

"Pyridostigmine Bromide: A Review of the Scientific Literature as it Pertain to Gulf War Illnesses." Testimony to Congress: House Veterans Affairs Committee, Health Subcommittee and Benefits Subcommittee. Washington DC: Nov 19, 1999.

Briefings to members of Senate subcommittees (Foreign Affairs and Veterans Affairs). Washington DC: Oct 19, 1999.

"Pyridostigmine Bromide: A Review of the Scientific Literature as it Pertain to Gulf War Illnesses." Briefing to representatives of multiple U.S. Veterans advocacy groups. Washington DC: Oct 19, 1999.

"Pyridostigmine Bromide: A Review of the Scientific Literature as it Pertain to Gulf War Illnesses." Press Briefing from the Pentagon. Washington DC: Oct 19, 1999.

"Pyridostigmine bromide and illness in Persian Gulf War veterans." Briefing to group consisting of: the Undersecretary of Health, the Undersecretary of the Army, the Surgeon General of the Army, the Principal Deputy for Health Affairs, representatives from the Surgeons General of the Navy and Air Force, several other generals, and the Directors of the Health and Defense Programs at RAND (The group convened for the exclusive purpose of hearing my briefing). Washington DC: Feb 3, 1998.

"RAND on PB and Immunizations." Presidential Special Oversight Board for Department of Defense Investigations of Gulf War Chemical and Biological Incidents. Arlington, VA: Oct 28, 1998.

"RAND Center for Military Health Policy Research: Gulf War Illness." (with Dr. Ross Anthony) Briefing to Major General James B. Peake, Commanding General/Commandant/ Installation Commander, US Army Medical Department Center and School. RAND Arroyo Center, Army Research Division. Santa Monica, CA: Oct 22, 1998.

"Health Effects of Service in the Gulf War." (with Dr. Ross Anthony) Briefing to DARPA and DSO (Defense Science Office. Arlington, VA: Sept 8, 1998.

"Health Effects of Service in the Gulf War." (with Dr. Ross Anthony) Briefing to Advisory Board of the National Defense Research Institute. RAND. Santa Monica, CA: May 5, 1998.

"Health Effects of Service in the Gulf War." (with Dr. Ross Anthony) Briefing to RAND Board of Trustees RAND’s 50th birthday. Washington DC: April 9, 1998.

"Pyridostigmine bromide and illness in Persian Gulf War veterans." Briefing to representatives from DoD, VA, FDA, PAC, and Congress. RAND Washington, Washington DC: Nov 4, 1997.

"Pyridostigmine bromide." Briefing to Israeli Defense and Health personnel, as part of a mission to the Middle East with Dr. Bernard Rostker (Assistant Secretary of the Navy; now Undersecretary of the Army) and others from the DoD. Tel Aviv, Israel: Nov 1 1997 (Participated in other briefings in the Middle East - Kuwait, Saudi Arabia, and Egypt - during a ~2 week trip).

Other Research Advisory Committee on Gulf War Veterans Illnesses Meetings Attended: Aug 13-15, 2006; Nov 5-6, 2006.

 

LECTURES, PRESENTATIONS

(See also Briefings to Government Agencies; and Abstracts)

“Patient Reporting of Drug Adverse Effects.” International Society of Pharmacovigilance, Accra, Ghana, Nov 3-6 (pending)

“Conflict of Interest.” CREST (Clinical Research Enhancement Through Supplemental Training, http://crest.ucsd.edu), La Jolla, CA, October 27 and 28, 2010 (Pending)

“Statins and Exercise.” Invited lecture, Sports Medicine conference, Mission Valley Marriott, Oct 22, 2010 (Pending)

“Statins, Q10 and mitochondrial function.” invited lecture, International Coenzyme Q10 Association Meeting, Brussels, Belgium May 29, 2010 (assisted by Dr. Peter Langsjoen).

“Statin Effects and Adverse Effects.” Rockefeller University, New York, Mar 17, 2010.

“Evidence Based Diet.” UCSD School of Medicine SOM410, From Principles to Practice, La Jolla, CA, Feb 23, 2010.

“Up Theirs. Rectal (and Swallowed) Foreign Bodies.” Invited talk, Ig Nobel Winners in San Diego, San Diego Marriott, Feb 19, 2010, http://improbable.com/airchives/miniair/2010/mini2010-02.htm

“Stacking the Deck.” Invited Talk, PRIME-LC group (medical students), UC Irvine, Feb 9, 2010.

“Stacking the Deck: Drug Benefits and Harms.” York University, Toronto, Canada, Jan 22, 2010

“Stacking the Deck.” ICES/CEU Conjoint Evaluative Sciences Rounds, University of Toronto, Jan 22, 2010

“Q10 for Gulf War Veterans.” Department of Defense research meeting, Hallmark Crowne Center, Kansas City, MO, Sep 2, 2009.

“Stacking the Deck.” Phil 12: Logic and Decision Making, Philosophy of Science, UC San Diego, Warren Lecture Hall, San Diego, CA, Aug 27, 2009.

“Evidence Based Diet.” Noon Conference, Veterans Affairs Medical Center, San Diego, CA, June 12, 2009.

“Evidence Based Diet.” Hebrew University School of Medicine, Jerusalem, Israel, June 3, 2009.

“Stacking the Deck: Drug Benefits and Harms.” The Technion School of Medicine, Haifa, Israel, June 2, 2009.

“Statin Effects.” The Technion School of Medicine, Haifa, Israel, June 1, 2009.

“Cholesterol and Behavior: From Case Reports to Population Data.” Invited presentation, seminar entitled Modeling anti-social behavior: lessons from cholesterol biosynthesis. Society for Biological Psychiatry 64th Annual Meeting, Vancouver: May 14-16, 2009.

“Statin Effects and Side Effects.” Cardiology Grand Rounds, San Diego Cardiac Center, Sharp Memorial Hospital, La Jolla, CA: April 17, 2009.

 “Gulf War Syndrome.” in Topics and Advances in Internal Medicine, University of California, San Diego School of Medicine, Hilton San Diego Resort, San Diego CA: March 9, 2009.

“Evidence Based Diet.” UCSD School of Medicine SOM410, From Principles to Practice, La Jolla, CA: Feb.17, 2009.

“Statin Side Effects” Preventive Medicine seminar, UC San Diego, La Jolla, CA: Feb 10, 2009.

“Aging.” San Diego Forum, La Jolla: CA: Jan 27, 2009.

“Pitfalls in the Application of Evidence.” The National Academies seminar What Can Be Learned from Public Health on the Role of Research for Policy Purposes?, Invited lecture to Division of Behavioral and Social Sciences and Education Standing Committee on Social Science Evidence for Use, The National Academies, Irvine, CA: Oct 30, 2008.

“Issues in the Identification and Communication of Drug Adverse Effects.” American Public Health Association, Invited lecture, San Diego, CA: Oct 27, 2008.

“This is Your Brain on Medical Politics.” Beyond Belief: Candles in the Dark, sponsored by The Science Network (tsntv.org), session entitled “This is Your Brain on Politics” Salk Institute, La Jolla, CA: Oct 5, 2008.  http://thesciencenetwork.org/programs/beyond-belief-candles-in-the-dark/beatrice-golomb

“Gulf War Syndrome.” General Internal Medicine Rounds, UC San Diego, La Jolla, CA: Aug 13, 2008.

“Dissent in Medicine: Stacking the Deck.” London School of Economics/UCSD Science Studies Program Dissent in Science: Origins and Outcomes Workshop, La Jolla, CA: Mar 3 2008. (Sponsored by AHRC (UK) as part of the Contingency and Dissent in Science project at the CPNSS, London School of Economics)

“Stacking the Deck: Drug Risks and Benefits.” Health Services Research & Development Scholarly Conference, Veterans Affairs San Diego Healthcare System, La Jolla CA: Feb 22, 2008.

“Evidence Based Diet.” UCSD School of Medicine SOM 410, From Principles to Practice, La Jolla, CA: Feb.19, 2008.

“Stacking the Deck: Treatment Risks and Benefits.” General Internal Medicine Grand Rounds, UCSD School of Medicine, La Jolla, CA: Jan. 30, 2008. 

“Simvastatin But Not Pravastatin Affects Sleep: Findings from the UCSD Statin Study.” American Heart Association annual meeting, oral presentation, Orlando, FL: Nov. 7, 2007.

“Statins: Risks and Benefits.” Grand Rounds, Scripps Green Hospital. La Jolla, CA: June 27, 2007.

“Statin side effects. A mitochondrial connection?” Invited talk, UC Irvine MitoMed group (mitochondrial medicine), Irvine, CA: June 18, 2007.

“Cholesterol, Heart Disease, and You.” UCSD Health and Wellness Series, Price Center, UCSD. La Jolla, CA: May 22, 2007.

“Statin Side Effects.” Invited Lecture, American College for Advancement in Medicine. Chicago, IL: May 13, 2007.

“Mitochondrial Dysfunction and Illness in Gulf War Veterans.” Research Advisory Committee on Gulf War Illness. Department of Veterans Affairs, Washington D.C.: April 24, 2007.

“Enhancing Post-marketing Drug Surveillance: A Response to Expressed Needs of Patients.” Robert Wood Johnson Foundation Generalist Physician Faculty Scholars Program Annual Meeting oral presentation, San Antonio, TX: Dec 1, 2006.

“Do Low Dose Statins Affect Cognition? Results of the UCSD Statin Study.” American Heart Association oral presentation, Chicago, IL: Nov. 15, 2006.

“Ethical Reasoning in Medicine – or the Contrary?” UCSD School of Medicine Biomedical Ethics Seminar: Sept 20, 2006.

“Stacking the Deck.” Health Services Research & Development, VA San Diego Healthcare Center. La Jolla, CA: July 20, 2006.

“Treatment risks vs benefits: Stacking the Deck.“ International Relations course IRGN490, UCSD, April 19, 2006.

“Gulf War Illness.” VA San Diego Healthcare Center. La Jolla, CA: April 14, 2006

“Do statins cause long term adverse effects?” Invited talk followed by invited panelist discussion, Panel: Controversies in Lipid Lowering Therapy, American College of Cardiology meeting. Atlanta, Georgia: March 12, 2006.

“Cholesterol and Violence.” Invited talk, San Diego Superior Court. San Diego, CA: Feb 7, 2006.

“Peer Review.” Invited talk, VA San Diego Healthcare center. La Jolla, CA: Dec 9 2005.

“Patient Targeted Adverse Event Surveillance: Use for Hypothesis Generation.” Robert Wood Johnson Generalist Physician Faculty Scholar meeting. Ft. Lauderdale, FL: Nov 10, 2005.

“Should statins be put in the water supply?” Distinguished Visitor Programme speaker, Biomedical Research Council, Agency for Science, Technology and Research (ASTAR). Singapore: Oct 25, 2005.

“Bridging the basic science/clinical science gap”. MSTP (Medical Scientist Training program -- MD/PhD program) retreat roundtable presentation. Aug 27, 2005.

“Conflict of interest”; CREST (Clinical Research Enhancement Through Supplemental Training, http://crest.ucsd.edu), Patient Oriented Research II: Ethics and regulation of human research. San Diego, CA: Aug 17, 2005; La Jolla, CA: Aug 18, 2005.

“A Scientific Career.” McNair Summer Research Program, UCSD. La Jolla, CA: July 2005.

“Clinical follow-up after stopping statin treatment.” Fourth Conference of the International Coenzyme Q10 Association. Los Angeles, CA: April 2005.

"Lack of Physician Response Toward Perceived Statin Adverse Events." 45th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in association with the Council on Nutrition, Physical Activity and Metabolism. April 2005.

“Drug benefits and harms: Stacking the deck.” Science Policy Analysis Roundtable series (http://acs.ucsd.edu/~spar/), UCSD. La Jolla, CA: March 10, 2005.

“Adverse Drug Effects: The Case of Statins.” UCSD Biomedical Ethics Seminar Series, UCSD. La Jolla: CA. Feb 16, 2005.

“Coenzyme Q10, Mitochondrial Function, Statins, and Aging.” Stein Institute for Research on Aging Grand Rounds, UCSD. La Jolla, CA: Jan 10, 2005.

“Should Statins be Put in the Water Supply?” Dept of Medicine, Yale. Newhaven, CT: July 21, 2004.

“CNS effects of low cholesterol.” UCSD Dept of Biology colloquium. La Jolla, CA: April 2004.

“Cholesterol and the brain”. UCSD Dept of Psychology colloquium. La Jolla, CA: March 16, 2004.

“Should statins be put in the water supply?” CTF C 301, UCSD. La Jolla, CA: March 10, 2004.

“Cholesterol and the brain: Mood, violence, and cognition.” Dept of Psychology, University of Southern California. Los Angeles, CA: Feb 11, 2004.

“Cardiovascular Prevention: Putting the Risk in Risk Benefit.” Department of Preventive Medicine, SUNY. Stonybrook, NY: Jan 27, 2004.

“The Great Debate. Do benefits of statins as currently used exceed the risks?” (with debaters John H. Lehman, John Robin Crouse and Michael J. Davidson) American College of Toxicology Annual Meeting. Washington DC: Nov 4, 2003.

“Anthrax Vaccine: Is it safe? Is it effective?” VA Faculty Development Seminar Series. La Jolla, CA: June 15, 2003.

"The Anthrax Vaccine: Is it safe and effective?" Epidemiology conference, Family and Preventive Medicine. La Jolla, CA: April 7, 2003.

"Research Recommendations: Focus on Acetylcholinesterase Mechanisms." Presentation to the Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses. Washington DC: Feb 2003.

"Recent Gulf War Illnesses Research." Presentation to the Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses/ Washington DC: Feb 2003.

"Acetylcholinesterase Inhibitors and Gulf War Illnesses." Presentation to the Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses. Washington DC: Nov 2002.

"Gulf War Veterans Illnesses: Treatment issues." Presentation to the Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses. Washington DC: Nov 2002.

"Mitochondrial function and Gulf War Illnesses." Presentation to the Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses. Washington DC: Nov 2002.

"A new perspective on cholesterol, statins, and heart disease." Stein Institute for Aging public lecture (televised for UCSD TV), La Jolla, CA: Aug 21, 2002.

"Putting the risk in risk benefit analysis." Dept of Medicine, Stonybrook School of Medicine. Stonybrook, NY: July 16, 2002.

AHA Debate: "Controversies in Preventive Cardiology Debate: NCEP ATP III Guidelines have not gone far enough."  Pro: Dr. John Robin Crouse. Con: Dr. Beatrice A. Golomb. American Heart Association Council on Epidemiology and Prevention, and American Society for Preventive Cardiology, 42nd Annual Conference on Cardiovascular Disease Epidemiology and Prevention. Honolulu, Hawaii: April 26, 2001.

"Cholesterol and Mood." UCSD Family & Preventive Medicine monthly conference, La Jolla, CA: Jan 15, 2002.

"The Angina Monologues." American Association of University Women: Oct 20, 2001.

"Restoring the risk to risk benefit analysis." Faculty Development series, VA San Diego Healthcare Center, La Jolla, CA: Oct 12, 2001.

"Syndromes without objective findings." 3rd Annual Federal Workers’ Compensation Conference, Chicago, IL: April 23, 2001.

"Cholesterol and Violence." UCSD Medical Scientist Training Program conference series, La Jolla, CA: Aug 6, 2001.

"Cholesterol." Rancho Carlsbad Health Fair, Carlsbad, CA: July 16, 2001.

"Cholesterol." VA San Diego Healthcare Center morning conference series, La Jolla, CA: June 15, 2001.

"Cholesterol and you," Plan for Wellness II, UCSD sponsored community lecture series, Mission Valley, La Jolla, CA: May 20, 2001.

"Stroke," Aging in the New Millenium, Academic Geriatric Resource Center, UCSD School of Medicine, La Jolla, CA: May 19, 2001.

"Cardiovascular Disease," Aging in the New Millenium, Academic Geriatric Resource Center, UCSD School of Medicine, La Jolla, CA: May 19, 2001.

"Hyperlipidemia," VASDHS morning conference series, La Jolla, CA: April 18, 2001.

"Statins and cognitive function," VASDHS morning conference, La Jolla, CA: March 16, 2001.

"Cholesterol and lipids," lecture to first year UCSD medical students, La Jolla, CA: Dec. 4, 2000.

"Putting the risk in risk-benefit analysis for cardiovascular disease," invited talk, American Heart Association, Annual Investigators Meeting, Research in Tobacco Related Illness, San Diego: Nov. 30, 2000.

"Restoring the risk to risk benefit analysis for cardiovascular disease," UC Irvine, Irvine, CA: Oct. 5, 2000.

"Gulf War Syndrome," UCSD Department of Medicine Grand Rounds, La Jolla, CA: Aug. 9, 2000.

"Cardiovascular Prevention: Putting the Risk in Risk-Benefit."  UCSD course (to international group of physicians), Topics and Advances in Internal Medicine, La Jolla, CA: Feb. 11, 2000.

"Medical Care: Restoring the Risk to Risk-Benefit Analysis," University of Chicago Health Sciences group; Chicago, IL: Feb. 8, 2000.

"Gulf War Illness," VASDHS Medicine Faculty Development series, La Jolla, CA: June 11, 1999.

"Aspirin for Primary Prevention of Coronary Artery Disease," Debate vs Dr. Leda Felicio. Dept of Medicine quarterly conference series, "Why Do We Do It?," VA San Diego Healthcare System, La Jolla, CA: March 26, 1999.

"Cholesterol and Violence: Where do we go from here?" Health Services Research and Development Seminar Series, San Diego VAMC/UC San Diego, La Jolla, CA: Feb. 11, 1999.

"Cholesterol and Violence," Colloquium, Social Science Research Institute, USC, Los Angeles, CA: Nov. 19, 1998.

"Cholesterol and Violence," Grand Rounds, Dept of Psychiatry, UC San Diego, La Jolla, CA: Nov 12, 1998.

Invited speaker and panelist: "How might interdisciplinary models of research guide us to a better understanding of violence?"  USC Interdisciplinary Perspectives for Understanding and Preventing Violence, co-sponsored by the Violence Prevention Coalition of Greater Los Angeles, Long Beach, CA: April 17, 1998.

"Cholesterol and Violence," Dept of Psychology Colloquium, UCSD, La Jolla, CA: April 16, 1998.

"Measurement and Management of Hyperlipidemia for the Primary Prevention of Coronary Heart Disease," with Dr. Michael H. Criqui.  Primary Care Grand Rounds, UCSD Dept of Family and Preventive Medicine, La Jolla, CA: April 15, 1998.

"The Cholesterol Controversy," VA San Diego Healthcare System quarterly "Why Do We Do It?" seminar, La Jolla, CA: March 29, 1997.

"Cholesterol and Violence: The Serotonin Connection," Mc Donnell Pew Research Center, Warner Springs Ranch, CA: March 15, 1997.

"Cholesterol and Violence," USC Dept. of Preventive Medicine, Los Angeles, CA: Feb 21, 1997

"The Cholesterol Controversy," San Diego VAMC, La Jolla, CA: Jan 10, 1997.

"Hyperlipidemia Panel Discussion"  Discussants: Alistair Fyfe, MD, PhD; B. Golomb, MD, PhD; David Heber, MD.  UCLA Department of Medicine Grand Rounds, Los Angeles, CA:  Aug 14, 1996.

"Cholesterol and Violence: Is There a Connection?"  RAND/UCLA Child and Adolescent Health Policy Seminar, RAND, Santa Monica, CA: July 9, 1996.

"Cholesterol and Violence: The Serotonin Connection," Telluride Summer Research Center Public Lecture, Telluride CO: July 5, 1996.

"Cholesterol and Violence: New Evidence," UCLA Health Services Research Seminar Series, Los Angeles, CA: June 21, 1996.

"Cholesterol Reduction: When is it Indicated?"  Cardiology Grand Rounds, Cedars Sinai Medical Center: June 18, 1996.

"Cholesterol, Serotonin, and Violence: Is there a Connection?," The Helmholtz Society, UC Irvine, Irvine, CA: June 11, 1996.

"Cholesterol Reduction in Primary Prevention: When is it Indicated?"  Cedars Sinai Medical Center, Health Services Research Group: March 6, 1996.

"Cholesterol Reduction: When and Who?"  St. Johns Medical Center, Santa Monica, CA: Nov 2, 1995.

"The Cholesterol Controversy," The Alzheimer Disease Research Consortium of Southern California, USC, Los Angeles, CA: April 21, 1995.

"Cholesterol Reduction in Primary Prevention," Debate vs Dr. David Leaf.  WLA VA Medical Center, Dept. of Medicine Grand Rounds, Los Angeles, CA: March 8, 1995.

"The Cholesterol Controversy," UCLA Dept. of Medicine Grand Rounds, Los Angeles, CA: Jan 11, 1995.

"Neural Networks Distinguish Demented Subjects from Elderly Controls based on EEGs," Neural Information Processing Systems conference, Neural Networks in Medicine workshop, Vail, CO: Dec. 3, 1994.

"Cholesterol Reduction in Primary Prevention: Rethinking the Evidence," UCLA Dept. of Endocrinology Grand Rounds, Los Angeles, CA: Sept. 21, 1994.

"Advance Directives," West Los Angeles VA Medical Center, Dept. of Medicine Conference, Los Angeles, CA: Sept. 16, 1994.

"The Cholesterol Myth," Grand Rounds, West Los Angeles V. A. Medical Center, Dept. of Medicine, Los Angeles, CA: June 8, 1994.

"Death by Hiccup," Reno V. A. Medical Center, Dept. of Medicine Conference, Reno NV: Feb. 1994.

"Hiccups," V. A. West Los Angeles Medical Center, Dept. of Medicine Conference, Los Angeles, CA: Jan. 1994.

"Neural Networks that Recognize Sex and Expressions from Faces," in international conference, Facial Expression: Brain, Perception, and Development, The Salk Institute, La Jolla, CA: April 6, 1991.

"SexNet: A neural network that distinguishes sex from face."  Neural Information Processing Systems, Spotlight presentation, Colorado: 1990.

 

PUBLICATIONS

RESEARCH PAPERS

Golomb BA, Erickson LC, Koperski S, Sack D, Enkin M, Howick J 2010. “What’s in placebos: Who knows? Analysis of randomized controlled trials.”Ann Intern Med (in press).

Rose N, Koperski S, Golomb BA 2010. ”Mood food: chocolate and depressive symptoms in a cross-sectional analysis.” Arch Intern Med. Apr 26;170(8):699-703.

Golomb BA, Yaghmai R, Renvall MJ, Ramsdell JW 2010. ”Electronic medical records and upper extremity symptoms: pain with the gain?” Arch Intern Med. Apr 12;170(7):655-657.

Cham S, Evans MA, Denenberg JO, Golomb BA 2010. ”Statin-associated muscle-related adverse effects: a case series of 354 patients.” Pharmacotherapy. 30(6): 541-553.

MacGregor AJ, Shaffer RA, Dougherty AL, Galarneau MR, Raman R, Baker DG, Lindsay SP, Golomb BA, Corson KS 2010. ”Prevalence and psychological correlates of traumatic brain injury in operation iraqi freedom.” J Head Trauma Rehabil. Jan-Feb;25(1):1-8.

Cham S, Gill K, Koperski S, Golomb BA 2009. ”Improvement in sleep apnea with switch from simvastatin to pravastatin.”  BMJ Case Reports [doi:10.1136/bcr.05.2009.1875]  http://casereports.bmj.com/cgi/content/abstract/2009/aug31_1/bcr0520091875.

MacGregor AJ, Corson KS, Larson GE, Shaffer RA, Dougherty AL, Galarneau MR, Raman R, Baker DG, Lindsay SP, Golomb BA 2009. ”Injury-specific predictors of posttraumatic stress disorder.” Injury. E-pub ahead of print. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19524912.

Linares L, Golomb B, Jaojoco J, Sikand H, Phillips PS 2009. ”The Modern Spectrum of Rhabdomyolysis: Drug Toxicity Revealed by Creatine Kinase Screening.” Curr Drug Saf. Sept 1. PMID: 19534642 E-pub ahead of print. URL: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19534642.

Golomb BA, Kwon E, Koperski SM, Evans MA 2009. ”Patient reports to the UCSD Statin Effects Study of amyotrophic lateral sclerosis-like conditions arising in apparent association with cholesterol-lowering drugs: hypothesized role for oxidative stress and mitochondrial injury.” Drug Safety 32(8):649-651.

Evans MA, Golomb BA 2009. “Statin associated cognitive problems reported by 171 subjects.” Pharmacotherapy 29(7): 800-11.

MacGregor AJ, Shaffer R, Wade A, Galarneau M, Raman R. Baker D, Lindsay S, Golomb B, Corson K 2009. ”Psychological correlates of battle and nonbattle injury among Operation Iraqi Freedom veterans: Results from the Navy-Marine Corps Combat Trauma Registry.” Military Medicine 174(3): 224-231.

Golomb BA, Evans MA 2008. "Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism.” Am J Cardiovasc Drugs; 8:373-418.

Golomb BA 2008. “Acetylcholinesterase Inhibitors and Gulf War Illnesses.” Proceedings of the National Academy of Science; 105(11): 4295-4300.

Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH 2008. “Reductions in Blood Pressure with Statins: Results from the UCSD Statin Study, a Randomized Trial.” Archives of Internal Medicine; 168(7): 721-727.

Golomb BA, McGraw JJ, Evans, MA, Dimsdale, JE 2007. "Physician Response to Patient Reports of Drug Adverse Effects: Implications for Patient-Targeted Adverse Effect Surveillance.” Drug Safety; 30(8): 669-675.

Golomb BA, Cortez-Perez M, Jaworski BA, Mednick SA, Dimsdale, JE 2007. “Point subtraction aggression paradigm: validity of a brief schedule of use.” Violence & Victims; 22(1): 95-103.

Golomb BA, Dang T, Criqui MH 2006. “Peripheral arterial disease: morbidity and mortality implications.” Circulation; 114: 688-699.

Wang JC, Criqui MH, Denenberg JO, McDermott MM, Golomb BA, Fronek A 2005 “Exertional leg pain in patients with and without peripheral arterial disease.” Circulation 112: 3501-8.

Golomb BA, Kane T, Dimsdale JE, 2004. "Severe irritability associated with statin cholesterol-lowering drugs." Quarterly J Med, 97:229-235.

Golomb BA, Criqui MH, White HL, Dimsdale JE 2004. "Study Design. The UCSD Statin Study: A randomized controlled trial assessing the impact of statins on noncardiac endpoints." Controlled Clinical Trials, 25:178-202.

Smythies J, Golomb BA, 2004. "Nerve gas antidotes." Journal of the Royal Society of Medicine, 97:32.

Golomb BA, Criqui MH, White HL, Dimsdale JE 2004. "Conceptual Foundations of the UCSD Statin Study: A Randomized Controlled Trial Assessing the Impact of Statins on Cognition, Behavior, and Biochemistry” Arch Intern Med; 164:153-162.

Criqui MH, Jamosmos M, Froniek A, Denenberg JO, Langer RD, Bergan J, Golomb BA 2003 ”Chronic venous disease in an ethnically diverse population: The San Diego Population Study.”  Am J Epidemiol, 158:448-456.

Golomb BA, Tenkanen, L, Alikoski T, Niskanen T, Manninen V, Huttunen M, Mednick SA 2002. ”Insulin sensitivity markers: Predictors of accidents and suicides in Helskinki Heart Study screenees.” Journal of Clinical Epidemiology, 55:1-7.

Bagley SC, White H, Golomb BA 2001.  "Use of logistic regression in the medical literature: Standard for use and reporting, with particular attention to one medical domain."  Journal of Clinical Epidemiology 54(10):979-985.

Golomb B, Vickrey G, & Hays RD 2001. "A review of health-related quality-of-life measures in stroke." Pharmacoeconomics, 19: 155-185.

Golomb BA, Stattin H, Mednick SA 2000.  "Low cholesterol and violent crime." J Psychiatric Res 34: 301-309.

Golomb BA, Pyne JM, Jaworski BA, Wright B, Lohr JM, Bozzette SA 2000.  "Primary care for patients with severe mental illness: What role can psychiatrists play?" Psychiatric Services 51(6): 766-773.

Golomb BA, Criqui MH, Detrano RC, Wong ND, Bundens WP, Mattrey RF, Denenberg JO 1999.  "Noninvasive testing to detect subclinical cardiovascular disease.  What is its role?" Preventive Cardiology 2(4):42-50 (Fall supplement).

Golomb BA 1998. "Cholesterol and violence: Is there a connection?" Annals of Internal Medicine, 128:478-487.

Criqui MH, Golomb BA 1998.  "Epidemiologic aspects of lipid abnormalities."  American Journal of Medicine, 105 (1A): 48S-57S.

Stewart-Bartlett M, Viola PA, Sejnowski TJ, Golomb BA, Larsen J, Hager JC and Ekman P 1996 "Classifying facial action." Advances in Neural Information Processing Systems  8: 823-829.

Gray MS, Lawrence DT, Golomb BA and Sejnowski TJ 1995. "A perceptron reveals the face of sex." Neural Computation, 7(6)1160-64.

Golomb BA, Lawrence DT, and Sejnowski TJ 1991. "SexNet: A neural network that recognizes sex from human faces." Advances in Neural Information Processing Systems 3, 572-577.

Golomb BA, Andersen RA, Nakayama K, MacLeod DIA, Wong A 1985. "Visual thresholds for shearing motion in monkey and man." Vision Research 25, 813-820.

 

EDITORIALS, INVITED PAPERS, OTHER

Golomb BA 2009. “Doctor·ing the Evidence: The case against lying to patients about placebos.” American Journal of Bioethics, 9:34-6. (Invited Editorial)

Golomb BA 2009. "Control Theory: Placebo-controlled drug trials have problems. Active-controlled drug trials are not always the solution." American Journal of Bioethics, 9 (9):67-69.  (Invited Editorial)

Golomb BA 2009. “Metabolic Syndrome: Intimal medial thickness and beyond.” J Am College Cardiol 53: 2280-2.  (Invited Editorial)

Golomb BA, Parrish J, Broadwin JA 2009. “Statins and Mortality.” On the Risk 25: 66-71. (Invited article for Insurance Industry journal)

Criqui MH, Golomb BA 2008. “Lipid lowering: what and when to monitor.“ Lancet 2008;372(9638):516-7.  (Invited Editorial)

Golomb BA 2007. “Reasoning from evidence. A call for education.”  Invited contribution to: Edge.org “What have you changed your mind about?” http://www.edge.org/q2008/q08_15.html#golomb

Golomb B 2007. “Odile reminiscences.” Odile Crick Memorial Exhibition, Edited by Becky Cohen, published by Salk Institute, p 23-24, 45.

Golomb BA 2006. “Reforming scientific and medical publishing via the internet.”  Invited contribution to: Edge.org “What are you optimistic about?” 

(Comment: Mine was the first of six Edge contributions highlighted on Nature’s website – Nature.com.)

Abbreviated version: http://edge.org/q2007/q07_15.html#golomb http://edge.org/q2007/q07_15.html#golomb

Full version: http://www.tsntv.org/articles/Golomb_Edge2007_expanded.pdf 

           See also Book Chapters (abbreviated version later published)

Golomb BA 2005. “Statins and Blood Pressure a Probable Link?” http://www.audiomedica.com/?p=52. Audio Journal of Cardiovascular Medicine, 11:1.

Golomb BA 2005. “Impact of statin adverse events in the elderly.” Expert Opinion on Drug Safety 4(3):389-397.

Criqui MH and Golomb BA 2004. “Low and lowered cholesterol and total mortality.” J Am Coll Cardiol 44(5): 1009-10.

Golomb BA 2004. “Statin side effects. Implications for the elderly.” Geriatric Times May/June, 18-20.

Criqui MH and Golomb BA 1999. "Should patients with diabetes drink to their health?" Journal of the American Medical Association 282 (3):279-80.

Golomb B and Criqui M 1999. "Anti-hypertensives: Much Ado About Lipids." Archives of Internal Medicine, 159: 535-537.

Golomb B 1998. "Dietary Fats and Heart Disease: Dogma Challenged." Journal of Clinical Epidemiology 51(6): 461-464.

Golomb BA 1995. "Are Placebos Bearing False Witness?” Chemistry and Industry 21: 900.

 

BOOKS

Golomb BA A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol 3: Immunizations RAND.  Unreleased.

Cecchine G, Johnson D, Perry W, Anthony C.R., Golomb B, Hearn A.C., Hilborne  L, Sollinger J. 2001. Army Medical Support to the Army After Next. RAND. 80 pages.

Hilborne LH, Golomb BA 2001. A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol 1: Infectious Diseases.  RAND, Santa Monica, CA.  119 pages. Peer reviewed book.

Cecchine G, Golomb BA, Hilborne LH, Spektor DM, Anthony RA 2000: A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol 8: Pesticides RAND, Santa Monica. 182 pages. Peer reviewed book.

Golomb BA 1999. A Review of the Scientific Literature as it Pertains to Gulf War Illnesses, Vol 2: Pyridostigmine Bromide. Washington, DC, RAND 385 pages.  Peer reviewed book. (Among top 10 best selling RAND books in 2000 list).

 

BOOK CHAPTERS

Golomb BA, Criqui MH 2008. "Epidemiology of PAD."  Chapter 1 In: MA Creager (Ed.), Peripheral Arterial Disease  (2nd Edition). ReMedica Publishing, London.  P 1-22.

Golomb B 2007 Reforming Scientific and Medical Publishing Via the Internet.” In: What Are You Optimistic About? Today's Leading Thinkers on Why Things Are Good and Getting Better,” John Brockman (Ed.), Harper Collins, New York. p 346-350.

Golomb BA, Criqui MH, Bundens WP 2001. "Epidemiology of peripheral arterial disease."  In: MA Creager (Ed.), Management of Peripheral Arterial Disease: Medical, Surgical and Interventional Aspects.  ReMedica Publishing, London. p 1-18.

Golomb BA, Criqui MH, Bundens WP 2001. "Peripheral arterial disease."  In Hiatt, W.R., Hirsch, A.T., Regensteiner, J. (Eds), Peripheral Arterial Disease Handbook. CRC Press, Boca Raton, pp. 57-80.

Golomb B 2000. "Health and Medical Factors: Cholesterol."  In: Violence in America - An Encyclopedia, Charles Scribner’s Sons.

Golomb BA 2000. "Cerebrovascular disease." In Kerr EA, Asch SM, Hamilton EG, McGlynn EA  (Eds.) Quality of Care for Cardiopulmonary Conditions: A Review of the Literature and Quality Indicators. RAND Health, Santa Monica: Pp 69-90.

Golomb BA 2000. "Chronic obstructive pulmonary disease." In Kerr EA, Asch SM, Hamilton EG, McGlynn EA (Eds.) Quality of Care for Cardiopulmonary Conditions: A Review of the Literature and Quality Indicators.   RAND Health, Santa Monica:  Pp 91-116.

Golomb BA 2000. "Hyperlipidemia."  In Kerr EA, Asch SM, Hamilton EG, McGlynn EA  (Eds.) Quality of Care for Cardiopulmonary Conditions: A Review of the Literature and Quality Indicators.   RAND Health, Santa Monica: Pp 201-216.

Golomb BA 2000. "Dyspepsia and Peptic ulcer disease." In Kerr EA, Asch SM, Hamilton EG, McGlynn EA  (Eds.) Quality of Care for General Medical Conditions A Review of the Literature and Quality Indicators.  RAND Health:  Pp 263-290.

Golomb B and Sejnowski TJ 1995. "Sex recognition from faces using neural networks."  In: AF Murray (Ed.), Applications of Neural Networks, Kluwer Academic Publishers.

 

TECHNICAL REPORTS AND RAND REPORTS (see also Books)

Binns JH, Barlow C, Bloom FE, Clauw DJ, Golomb BA, et al 2008. Gulf War Illness and the Health of Gulf War Veterans. Scientific Findings and Recommendations. Research Advisory Committee on Gulf War Veterans Illnesses. US Government Printing Office, Washington, D.C. 454 pages. November 2008.

Binns JH, Cherry N, Golomb BA, et al. Research Advisory Committee on Gulf War Veterans' Illnesses: Scientific Progress in Understanding Gulf War Veterans’ Illnesses: Report and Recommendations. http://www1.va.gov/rac-gwvi/docs/ReportandRecommendations_2004.pdf; 2004 September 2004.

Golomb BA 2003. Research Recommendations. Written brief for Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses.

Golomb BA, Pickett D 2003. Surveillance for birth defects in ill Gulf War veterans. Written brief for Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses.

Golomb BA. 2002. Acetylcholinesterase inhibitor effects: Neurological and nonneurological mechanisms. Written brief for Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses.

Golomb BA. 2002. Mitochondrial dysfunction. A mechanism of illness in Gulf War veterans? Written brief for Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses.

Golomb BA, Chadwick A. 2002. Treatment considerations for ill Gulf War veterans. Written brief for Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses.

Golomb BA, Haley R 2002. Objective Markers: Means to Identify Mechanisms and Treatments in Gulf War veterans. Written brief for Dept of Veterans Affairs Research Advisory Committee on Gulf War Illnesses.

Golomb B 1999.  Assessing the Care of Vulnerable Elders.  Potential Quality Indicators and Literature Review: Stroke.  RAND report. 113 pages.

Perry W, Johnson D, Cecchine G, Golomb B, Hilborn L, Hearn A, Anthony R 1999.  Issues and Insights from the Army Medical Technology Workshop, 1999. Prepared for the US Army Training and Doctrine Command and the US Army Medical Department.  RAND report PM-946-A, July 1999.

Hays RD, Vickrey BG, Golomb B 1997. "Health related quality of life measures in studies of stroke." RAND report, July 1997.

Sherbourne CD, Golomb BA, Bystritsky A, Inkeles M, Marshall G. "Summary of Health-related Quality of Life Measures for Use in Anxiety Disorders." RAND report, July 1997.

Gray MS, Lawrence DT, Golomb BA and Sejnowski TJ 1993.  "A perceptron reveals the face of sex." Institute for Neural Computation Technical Report Series, INC-9303.

 

LETTERS TO THE EDITOR

Golomb BA, Koperski S, Rose, N 2010. “Confection in coinfection [title will likely be different],” Arch Intern Med in press.

Golomb BA, Koperski S, Evans MA 2010. “Statin adverse effects. A complementary perspective.” Drug Safety in press.

Golomb BA 2009. “The forecast remains sunny for the vitamin D heart hypothesis.” Arch Internal Med in press (scheduled publication Sept 14 issue).

Golomb BA, Koperski S 2009. “Association Not Causation.” Arch Internal Med 169:1079.

Golomb BA, Aranoff-Spencer E, Steadman MC, Wu W, Yan A 2009. “A ray of sunshine for the Vitamin D Heart hypothesis.” Arch Internal Med 169(4): 416-7

Golomb BA, Evans MA 2008. “Re: Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.“ Neurology 70(24): 2349-50

Golomb BA 2008. Correction for Golomb, "Reply to Blazer et al.: Flawed challenges to 'Acetylcholinesterase inhibitors and Gulf War illnesses'." Proc Natl Acad Sci U S A 105(47): E94. (This was a correction of their error – the journal had made a change after the galleys were approved, that they later corrected)

Golomb BA 2008. Reply to Blazer et al.: flawed challenges to "Acetylcholinesterase inhibitors and Gulf War illnesses." Proc Natl Acad Sci U S A 105(33): E53

Golomb BA, Mednick SA, Tenkanen L 2007. “Suicide: A weighty matter?” Arch Internal Med 167(17): 1908.

Golomb BA, Evans MA 2007. “Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease.” Med J Australia 187(4): 253.

Golomb BA, Evans MA 2006. “Risk factors for rhabdomyolysis with simvastatin and atorvastatin.” Drug Safety 29(12): 1191.

Golomb BA 2002. "When are medication side effects due to the nocebo phenomenon?" JAMA 287(19): 2502-3; discussion 2503-4.

Kaplan RM, Golomb BA 2001. "Cost-effectiveness of statin medications." Am Psychol 56(4): 366-7.

Golomb BA and Jaworski BA 2001. "Statins and Dementia." Archives of Neurology 58(7): 1169-70.

Golomb BA 1998. "Cholesterol and violence: Is there a connection?" Annals of Internal Medicine 129(8): 669-670.

Golomb BA 1996. "Low serum cholesterol and serotonin metabolism -- other studies have been done in humans and monkeys."  BMJ 312(7041):1299.

Golomb BA 1996. "Using placebos," Nature 379: 765.

Golomb BA 1995. "Low cholesterol and violence," Arch Intern Med 155: 2485.

Golomb BA 1995. "Paradox of placebo effect," Nature 375: 530.

Golomb B 1990. "Hiccup for hiccups," Nature 345: 774.

Golomb B 1989. "Taking a byte out of time," JAMA 262: 3132.

 

BOOK REVIEWS

Golomb BA 1997. "Catalyst -- For Change in Book Reviews," Chemistry and Biology 4: 651-652.

Golomb BA 1996. "Genius talk or moron babble?  The complementarity principle," Chemistry and Biology 3: 813-814.

Golomb BA 1995. "Author's Imagination" (Review of Nature's Imagination: The Frontiers of Scientific Vision), Chemistry and Biology 2(10): 651-2.

 

THESIS

Golomb BA 1988. "Visual Motion Processing: Some Special Properties," PhD Thesis, Department of Biology, U. C. San Diego.

 

ABSTRACTS

Golomb BA, Criqui MH, Dimsdale JE, Evans MA, Broadwin JA, White HL 2009 “Statin effects on energy: Results from the UCSD Statin Study, a randomized trial.” Circulation 119: e308. (Joint Conference – 49th Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference. Abstract ID 837, March 11, Palm Harbor, Florida, presented 3-11-09)

Golomb BA, Broadwin JA, White HL, Criqui MH, Dimsdale JE 2009. “Statins reduce orgasm. Results from the UCSD Statin Study, a randomized trial.”American Psychosomatic Society, March 6, Chicago (presented 3-6-09)

Golomb BA, Evans MA, Dimsdale JE 2008. “Trans Fat Consumption Linked to Aggression.” Circulation supplement; 117(11):e237. Presented at the American Heart Association 48th Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Colorado Springs.

Golomb BA, Dimsdale JE, Evans MA, Denenberg JO, White HL, Criqui MH 2008. “Effects of Statins on Aggression Differ by Gender: Results of a Double Blind Placebo Controlled Trial.” Circulation supplement; 117(11):e268-269. Presented at the American Heart Association 48th Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Colorado Springs.

Golomb BA, Kwon EK, Criqui MH, Dimsdale JE 2007. “Simvastatin But Not Pravastatin Affects Sleep: Findings from the UCSD Statin Study.” Circulation supplement; 116:II-847.

R Yaghmai; MJ Renvall; BA Golomb; LA Lenert; JW Ramsdell 2007. “An Epidemic Of Musculoskeletal Symptoms Among Physicians In Two Institutions Using EMR-Based Systems For Routine Care.” Poster presentation/abstract, Society of General Internal Medicine meeting, Toronto, Canada: April 25-28, 2007.

Golomb BA, Dimsdale JE, White HL, Criqui MH 2006. “Do Low Dose Statins Affect Cognition? Results of the UCSD Statin Study.” Circulation supplement; 114(18): II-289.

Golomb BA, McGraw J 2005. "Lack of Physician Response Toward Perceived Statin Adverse Events." Circulation supplement.

Golomb BA, Ritchie JB, Criqui MH, Dimsdale JE. 2004. Statins Lower Blood Pressure: Results from the UCSD Statin Study. Circulation (suppl 3) 110(17): 402.

Kordas K, Phillips P, Golomb B 2004. Clinical Characteristics of 1053 Patients with Statin-Associated Muscle Complaints. Arterioscler Thromb Vasc Biol; 24:e51-136.

Golomb BA, Yang E, Denenberg J, Criqui MH 2003. "Statin Associated Muscle Adverse Effects." Poster presentation/abstract, AHA Council on Epidemiology and Prevention meeting, Miami FL: March 7, 2002.

Yang E, Jaworski B, Denenberg J, Criqui MH, Golomb BA 2002. Muscle symptoms in patients on statins. American Heart Association Young Investigators Forum, San Diego, CA: Sept. 2002.

Golomb, BA 1999. "Could dysregulation of acetylcholine (from pyridostigmine bromide or other acetylcholinesterase inhibitors) contribute to illness in Persian Gulf War veterans?" Conference on Federally Sponsored Gulf War Veterans’ Illnesses Research, June 23-25, 1999 (Abstract accepted; withdrawn for security reasons at request of DoD).

Golomb BA and Criqui MH 1998. "Put the risk back in risk-benefit," 1998 San Diego Biostatistics & Epidemiology Research Exchange Conference. La Jolla, CA (Platform presentation May 5, 1998).

Bagley S and Golomb BA 1998. "Patient interest and response to genetic testing for cancer susceptibility: A systematic review of the literature," American Federation for Medical Research, Western Regional Meeting, Feb 4-7, 1998, Carmel, CA.  J Investigative Medicine 46(1).

Pyne J, Golomb B, Schten E, Jaworski B, Bozzette S 1998. "Appropriate roles for psychiatrists delivering primary medical care," VA HSR&D meeting, Feb 1998.

Golomb BA 1996. "Low cholesterol and Violent Crime," Proceedings of the Robert Wood Johnson Clinical Scholars Program 24th National Meeting, Ft. Lauderdale, FL. (Platform presentation: Nov 1996).

Golomb BA 1995. "Cholesterol, serotonin, and violence: Is there a connection?" Proceedings of the Robert Wood Johnson Clinical Scholars Program 23rd National Meeting, Ft. Lauderdale, FL. (Platform presentation: Nov 9, 1995).

Golomb B and Leuchter AF 1993. "Neural Networks Distinguish Demented Patients from Elderly Controls Based on EEG Recordings," Solomon Scholar Research Award, UCLA. (Platform presentation: June 1993).

Golomb B, Lawrence D, Sejnowski T, and Ekman P 1992. "Neural Networks Evaluate Facial Muscle Actions," Solomon Scholar Research Award, UCLA, 1992. (Platform presentation, June 1992).

Golomb B 1990. "Cross adaptation to flow field motion," Investigative Ophthalmology and Visual Science 31 (4):522.  Poster presentation, Association for Research in Vision and Ophthalmology, Sarasota, FL, April 1989.

Golomb B 1988. "Motion Escape," Investigative Ophthalmology and Visual Science 29.  Poster presentation, Association for Research in Vision and Ophthalmology, Sarasota, FL, April 1988.

Golomb B 1986. "The Crankshaft Effect," Investigative Ophthalmology and Visual Science 27(3): 345.  Poster presentation, Association for Research in Vision and Ophthalmology, Sarasota, FL, April 1986.

Golomb B, Andersen, RA, Nakayama, K, MacLeod, DIA, Wong, A. 1984. "Thresholds for shearing motion detection in monkey and man," Investigative Ophthalmology and Visual Science 25(3):69. Poster presentation, Association for Research in Vision and Ophthalmology, Sarasota, FL, April 1984.

 


MEDIA INTEREST (Incomplete)
Recent:

2010   Time magazine, Scientific American, CNN, BBC News, Wall Street Journal, LA Times, Business Week (both News and Lifestyle sections), AOL, ABC News, CBS News, CANWorld, KNBC TV, Mens Health, Women’s Health, FDA Reporter, The Globe and Mail (Canada), Radio New Zealand, UK Press Association, NPR, Reuters, Bloomberg News, CNN Health.com, CAN West news (Canada), LA Times (x 2), the Australian, Fox, Fox Business.com, Boston Global, Chicago Tribune, Denver Post, Discovery Health, Montreal Gazette, MSN, MSNBC, The Austrialian, The Daily Mail (UK), Time magazine (again),Times (India), Medscape, United Press International, WebMD, Xinhua News, Yahoo News, many others.

Our April 2010 article on chocolate and depression in Archives of Internal Medicine (Google: chocolate depression Archives April 2010) led to hundreds of news stories extending to at least 50 foreign nations per Google News – the runaway big story for our University that month, and still the number 2 health story on CNN a month later (with stories still being run in major media).

2009:  NBC TV (San Diego News Now!), USA Today (section A story), CNN radio, 60 minutes, Forbes, The Globe and Mail (Canada), WebMD, San Diego Union Tribune (front page story).

2008:  BBC, Bloomberg News, Business Week, CNN, Daily Mail (UK), Daily Telegraph (UK), Discovery, Economist, Good Morning America (ABC TV), LA Times, New Scientist, New York Times, Reuters, The Australian (Australia), The Doctors (TV show), US News and World Report, Wall St Journal, Washington Post.

Mostly Previous:

Statin Adverse Effect website:

Wall Street Journal. “Researchers Ask Patients to Help Fill Gap in Data on Side Effects of Statins.” Tara Parker-Pope 10/3/2006

United Press International. “Statin Users Report Side Effects Online.” Leah Carliner. 9/22/2006; Channel 10 television news, San Diego, Carol LeBeau

ABC7 News.com. Risks & Benefits of Statin Drugs.”

Washington Post Online, Reuters Online, MSNBC Online, KPBS,

American Heart Association, WebMD, Fox News, LA Times. “Cholesterol-lowering drug linked to sleep disruptions.”

The New York Times. “Data about zetia risks was not fully revealed.” Dec 21, 2007.

The New York Times. “Can Statins Make You Stupid?” Tara Parker-Pope. 2/13/2008.

 

Cholesterol; and Statin risk-benefit:

11-97 KNBC TV; 3-98 New York Times 5 column article, CNN, NBC, ABC, CBS, LA Times, Reuters/AP, Science magazine. Also, British newspapers.

NBC Nightly News, 8-24-01. NBC Nightly News, 11-13-01. Wall Street Journal, 4-25-02.  MSNBC (print) 8-24-01.Wall Street Journal, 12-02. San Diego Union Tribune 5-03. Los Angeles Times 7-03. Wall Street Journal 1-04. New York Times 7-04. CBS News with Dan Rather 5-04.  Newsday 7-04.  The San Diego Union Tribune 7-04. The Times (London) 8-04.

           Other: Multiple newspapers throughout US 7-00, 9-00; LA Times, 2000 & 2001. San Diego Union Tribune, 5-16-01 & 5-28-01 (front page article); Philadelphia Enquirer 8-27-01. Sciences et Avenir (France), 10-01. WebMD (peripheral neuropathy) 5-02. Discover magazine. KPBS radio 5-29-02 10-11 "These Days"; with Tom Fudge and Dr. Michael Criqui; UCSD TV, lecture 8-02. Men's Health, San Francisco Chronicle 1-05. The Sunday Times-Britain 3-05. San Diego Union Tribute 7-05. Lifetime Fitness 12-05. Daily News (UK) 6-06. Daily Mail (UK) 6-06. BusinessWeek 8-06. Daily Mail (UK) 1-07. ABC7News.com 2-07. Smart Money

The New York Times. “Great Drug, but Does It Prolong Life?” Tara Parker-Pope. 1/29/2008

Ladies' Home Journal. “Does Cholesterol Really Count?” Linda Marsa. Feb-08

Business Week

The Wall Street Journal. “Can a Drug That Helps the Heart be Harmful to the Brain?” Melinda Beck. 2/12/2008.

Good Morning America 2-08

Israeli press (Hebrew symbols)

 

Gulf War illness,

Following Pentagon press briefing 10-99 (and interviews)

NY Times and LA Times (front page of each); Washington Post, San Diego Union Tribune, multiple other newspapers; NPR, other radio stations, national TV news on ABC and CBS (lead story), NBC; CNN, CSPAN; policy.com, Yahoo (lead news story), The Daily Show with Jon Stewart (lead “Headline News” story); science journals including New Scientist. BBC radio interview, BBC television, television news throughout Western Europe (e.g. Britain, Germany, other), Eastern Europe, Australia; newspapers and news magazines throughout same distribution (10-99) -- e.g. Le Monde (France), Hungarian newspapers and news magazines, Danish periodicals, German, BBC news

Following Congressional testimony in 11-99: CNN.

Subsequent: Science magazine 4-01. Science magazine 4-02. NPR Science Friday (radio guest) 3-03.

On release of Committee report 2004: Front page article NY Times 10-15-04; Front page San Diego Union Tribune 10-15-04; BBC radio 10-15-04 (or 10-16); London Times; Others internationally.;Science Magazine; BMJ (news section); BBC News (and BBC radio) 10-04.  BMJ News Extra 10-04.  

“Study: Sarin at Root of Gulf War Syndrome.” Kelly Kennedy. Army Times. 5/25/2007

Following PNAS article on acetylcholinesterase inhibitors and illness in Gulf War veterans: BBC radio 3-08; CNN radio 3-08, Economist 3-08; other UK media/ press, The Australian (leading Australian daily), German radio interview, LA Times, Reuters, Washington Post, San Diego Union Tribune, Bloomberg News, many other venues

Following Gulf War RAC Committee Report: Nov 2008: most major news venues

 

Pyridostigmine FDA approval for Nerve Agent Protection 3-03: Science magazine, multiple regional papers (e.g. Rocky Mountain Times, Orange County Register)

 

Cholesterol and violent crime: Web MD 2000; Clinical Pearls 2001; Crime Times 2001

 

Alcohol and diabetes: re: JAMA article: 7-99: Fox News, Science News, other

Neural networks, pertaining to SexNet and ExpressionNet: 1990 CNN; 1990 Jim Jubek, In the Image of the Brain (Popular book on neural network revolution); 1992, The Machine that Changed the World, Episode 4: The Thinking Machine (A PBS NOVA Documentary).









  1. Navigate:

  2. Welcome | Study Information | Current Questionnaires | Standard Participant Forms |
    Special Situations | Background | Contribute | Contact Us | About Dr. Golomb


 

CURRICULUM VITAE

Beatrice Alexandra Golomb, MD, PhD

Dept of Medicine 0995

9500 Gilman Dr. / La Jolla, CA 92093-0995

Phone: (858) 558-4950 x201

Fax: (858) 558-4960